188 related articles for article (PubMed ID: 11311458)
1. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention.
Coleman MD
Toxicology; 2001 Apr; 162(1):53-60. PubMed ID: 11311458
[TBL] [Abstract][Full Text] [Related]
2. Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone).
Booth F; Barker LC; Barton CJ; Naik RB
Postgrad Med J; 1984 Aug; 60(706):566-7. PubMed ID: 6473241
[TBL] [Abstract][Full Text] [Related]
3. Agranulocytosis associated with maloprim: review of cases.
Hutchinson DB; Whiteman PD; Farquhar JA
Hum Toxicol; 1986 Jul; 5(4):221-7. PubMed ID: 3733111
[TBL] [Abstract][Full Text] [Related]
4. Agranulocytosis--a case report.
Rahman J; Chowdhury SA; Wajed J
Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):65-8. PubMed ID: 11508074
[TBL] [Abstract][Full Text] [Related]
5. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
[TBL] [Abstract][Full Text] [Related]
6. Dapsone and sulfapyridine.
Paniker U; Levine N
Dermatol Clin; 2001 Jan; 19(1):79-86, viii. PubMed ID: 11155588
[TBL] [Abstract][Full Text] [Related]
7. Agranulocytosis associated with malaria prophylaxis with Maloprim.
Friman G; Nyström-Rosander C; Jonsell G; Björkman A; Lekås G; Svendsrup B
Br Med J (Clin Res Ed); 1983 Apr; 286(6373):1244-5. PubMed ID: 6404407
[No Abstract] [Full Text] [Related]
8. Agranulocytosis associated with Maloprim.
Bruce-Chwatt LJ; Hutchinson DB
Br Med J (Clin Res Ed); 1984 Jan; 288(6410):65-6. PubMed ID: 6418319
[No Abstract] [Full Text] [Related]
9. Maloprim and agranulocytosis.
Bruce-Chwatt LJ; Hutchinson DB
Lancet; 1983 Dec 24-31; 2(8365-66):1487-8. PubMed ID: 6140569
[No Abstract] [Full Text] [Related]
10. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.
Hörnsten P; Keisu M; Wiholm BE
Arch Dermatol; 1990 Jul; 126(7):919-22. PubMed ID: 2360840
[TBL] [Abstract][Full Text] [Related]
11. Dapsone-induced agranulocytosis-possible involvement of low-activity N-acetyltransferase 2.
Potočnjak I; Likić R; Šimić I; Juričić Nahal D; Čegec I; Ganoci L; Božina N
Fundam Clin Pharmacol; 2017 Oct; 31(5):580-586. PubMed ID: 28322460
[TBL] [Abstract][Full Text] [Related]
12. Hyperpigmented dermal macules in children following the administration of Maloprim for malaria chemoprophylaxis.
David KP; Marbiah NT; Lovgren P; Greenwood BM; Petersen E
Trans R Soc Trop Med Hyg; 1997; 91(2):204-8. PubMed ID: 9196770
[TBL] [Abstract][Full Text] [Related]
13. Dapsone agranulocytosis in a leprosy patient.
Hiran S; Pande TK; Pani S; Vishwanathan KA
Lepr Rev; 1994 Sep; 65(3):279-81. PubMed ID: 8942159
[TBL] [Abstract][Full Text] [Related]
14. Agranulocytosis associated with Maloprim.
Br Med J (Clin Res Ed); 1983 May; 286(6376):1515. PubMed ID: 6405867
[No Abstract] [Full Text] [Related]
15. [Dapsone-induced agranulocytosis. The role of xenobiotic-metabolizing enzymes demonstrated by a case report].
Hoffmann TK; von Schmiedeberg S; Wulferink M; Thier R; Bier H; Ruzicka T; Lehmann P
Hautarzt; 2005 Jul; 56(7):673-7. PubMed ID: 15999287
[TBL] [Abstract][Full Text] [Related]
16. Chemoprophylaxis of malaria in Africa.
Rée GH
Br Med J (Clin Res Ed); 1983 Feb; 286(6364):562. PubMed ID: 6402151
[No Abstract] [Full Text] [Related]
17. A comparative study of Lapudrine (chlorproguanil) and Maloprim (pyrimethamine and dapsone) as chemoprophylactics against malaria in Gambian children.
Greenwood BM; Greenwood AM; Smith AW; Menon A; Bradley AK; Snow RW; Sisay F; Bennett S; Watkins WM; N'Jie AB
Trans R Soc Trop Med Hyg; 1989; 83(2):182-8. PubMed ID: 2692227
[TBL] [Abstract][Full Text] [Related]
18. Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria.
Lee PS; Lau EY
Br Med J (Clin Res Ed); 1988 Mar; 296(6626):893-5. PubMed ID: 3129063
[TBL] [Abstract][Full Text] [Related]
19. Maloprim--general toxicity or idiosyncrasy?
Vergara RV
P N G Med J; 1984 Mar; 27(1):46. PubMed ID: 6595907
[No Abstract] [Full Text] [Related]
20. Agranulocytosis due to dapsone.
Firkin FC; Mariani AF
Med J Aust; 1977 Aug; 2(8):247-51. PubMed ID: 909500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
